HIV Env reduction postreceptor binding: a new target for AIDS treatment?
Fenouillet
Emmanuel
E
Barbouche
Rym
R
Jones
Ian M
IM
D015704:CD4 Antigens / Q000378:metabolism; D004220:Disulfides / Q000737:chemistry / Q000378:metabolism; D015686:Gene Products, env / Q000378:metabolism*; D015658:HIV Infections / Q000188:drug therapy; D015497:HIV-1 / Q000378:metabolism* / Q000472:pathogenicity; D006801:Humans; D008561:Membrane Fusion / Q000187:drug effects; D010084:Oxidation-Reduction; D011485:Protein Binding; D011487:Protein Conformation; D019704:Protein Disulfide-Isomerases / Q000378:metabolism; D019718:Receptors, CXCR4 / Q000378:metabolism; D015728:Receptors, HIV / Q000378:metabolism*; D019163:Reducing Agents / Q000494:pharmacology
D015704:CD4 Antigens; D004220:Disulfides; D015686:Gene Products, env; D019718:Receptors, CXCR4; D015728:Receptors, HIV; D019163:Reducing Agents; D019704:Protein Disulfide-Isomerases